SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-042073
Filing Date
2023-08-14
Accepted
2023-08-14 08:01:13
Documents
63
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q vcnx-20230630.htm   iXBRL 10-Q 1762674
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 OF THE SARBANES vcnx-ex31_1.htm EX-31.1 29736
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 OF THE SARBANES vcnx-ex31_2.htm EX-31.2 29709
4 CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER PURSUANT TO vcnx-ex32_1.htm EX-32.1 16625
  Complete submission text file 0000950170-23-042073.txt   6216003

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vcnx-20230630_pre.xml EX-101.PRE 280696
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vcnx-20230630_lab.xml EX-101.LAB 397186
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vcnx-20230630_cal.xml EX-101.CAL 27778
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vcnx-20230630.xsd EX-101.SCH 49320
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vcnx-20230630_def.xml EX-101.DEF 164345
57 EXTRACTED XBRL INSTANCE DOCUMENT vcnx-20230630_htm.xml XML 954085
Mailing Address 1895 MOUNT HOPE AVE ROCHESTER NY 14620
Business Address 1895 MOUNT HOPE AVE ROCHESTER NY 14620 585-271-2700
VACCINEX, INC. (Filer) CIK: 0001205922 (see all company filings)

IRS No.: 161603202 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38624 | Film No.: 231166405
SIC: 2834 Pharmaceutical Preparations